×




ESSA Pharma (EPIX) SWOT Analysis / TOWS Matrix / MBA Resources

Introduction to SWOT Analysis

SWOT Analysis / TOWS Matrix for ESSA Pharma (United States)


Based on various researches at Oak Spring University , ESSA Pharma is operating in a macro-environment that has been destablized by – customer relationship management is fast transforming because of increasing concerns over data privacy, digital marketing is dominated by two big players Facebook and Google, increasing commodity prices, wage bills are increasing, challanges to central banks by blockchain based private currencies, geopolitical disruptions, increasing government debt because of Covid-19 spendings, technology disruption, there is backlash against globalization, etc



12 Hrs

$59.99
per Page
  • 100% Plagiarism Free
  • On Time Delivery | 27x7
  • PayPal Secure
  • 300 Words / Page
  • Buy Now

24 Hrs

$49.99
per Page
  • 100% Plagiarism Free
  • On Time Delivery | 27x7
  • PayPal Secure
  • 300 Words / Page
  • Buy Now

48 Hrs

$39.99
per Page
  • 100% Plagiarism Free
  • On Time Delivery | 27x7
  • PayPal Secure
  • 300 Words / Page
  • Buy Now







Introduction to SWOT Analysis of ESSA Pharma


SWOT stands for an organization’s Strengths, Weaknesses, Opportunities and Threats . At Oak Spring University, we believe that ESSA Pharma can use SWOT analysis as a strategic management tool to assess the current internal strengths and weaknesses of the ESSA Pharma, and to figure out the opportunities and threats in the macro environment – technological, environmental, political, economic, social, demographic, etc in which ESSA Pharma operates in.

According to Harvard Business Review, 75% of the managers use SWOT analysis for various purposes such as – evaluating current scenario, strategic planning, new venture feasibility, personal growth goals, new market entry, Go To market strategies, portfolio management and strategic trade-off assessment, organizational restructuring, etc.




SWOT Objectives / Importance of SWOT Analysis and SWOT Matrix


SWOT analysis of ESSA Pharma can be done for the following purposes –
1. Strategic planning of ESSA Pharma
2. Improving business portfolio management of ESSA Pharma
3. Assessing feasibility of the new initiative in United States
4. Making a sector specific business decision
5. Set goals for the organization
6. Organizational restructuring of ESSA Pharma




Strengths of ESSA Pharma | Internal Strategic Factors
What are Strengths in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis

The strengths of ESSA Pharma are -

Innovation driven organization

– ESSA Pharma is one of the most innovative firm in sector.

Strong track record of project management in the industry

– ESSA Pharma is known for sticking to its project targets. This enables the firm to manage – time, project costs, and have sustainable margins on the projects.

Learning organization

- ESSA Pharma is a learning organization. It has inculcated three key characters of learning organization in its processes and operations – exploration, creativity, and expansiveness. The work place at ESSA Pharma is open place that encourages instructiveness, ideation, open minded discussions, and creativity. Employees and leaders at ESSA Pharma emphasize – knowledge, initiative, and innovation.

Sustainable margins compare to other players in industry

– ESSA Pharma has clearly differentiated products in the market place. This has enabled ESSA Pharma to fetch slight price premium compare to the competitors in the industry. The sustainable margins have also helped ESSA Pharma to invest into research and development (R&D) and innovation.

Ability to lead change in

– ESSA Pharma is one of the leading players in the industry in United States. Over the years it has not only transformed the business landscape in the industry in United States but also across the existing markets. The ability to lead change has enabled ESSA Pharma in – penetrating new markets, reaching out to new customers, and providing different value propositions to different customers in the international markets.

High switching costs

– The high switching costs that ESSA Pharma has built up over years in its products and services combo offer has resulted in high retention of customers, lower marketing costs, and greater ability of the firm to focus on its customers.

Cross disciplinary teams

– Horizontal connected teams at the ESSA Pharma are driving operational speed, building greater agility, and keeping the organization nimble to compete with new competitors. It helps are organization to ideate new ideas, and execute them swiftly in the marketplace.

Analytics focus

– ESSA Pharma is putting a lot of focus on utilizing the power of analytics in business decision making. This has put it among the leading players in the industry. The technology infrastructure of United States is also helping it to harness the power of analytics for – marketing optimization, demand forecasting, customer relationship management, inventory management, information sharing across the value chain etc.

Digital Transformation in industry

- digital transformation varies from industry to industry. For ESSA Pharma digital transformation journey comprises differing goals based on market maturity, customer technology acceptance, and organizational culture. ESSA Pharma has successfully integrated the four key components of digital transformation – digital integration in processes, digital integration in marketing and customer relationship management, digital integration into the value chain, and using technology to explore new products and market opportunities.

Diverse revenue streams

– ESSA Pharma is present in almost all the verticals within the industry. This has provided ESSA Pharma a diverse revenue stream that has helped it to survive disruptions such as global pandemic in Covid-19, financial disruption of 2008, and supply chain disruption of 2021.

Effective Research and Development (R&D)

– ESSA Pharma has innovation driven culture where significant part of the revenues are spent on the research and development activities. This has resulted in – ESSA Pharma staying ahead in the industry in terms of – new product launches, superior customer experience, highly competitive pricing strategies, and great returns to the shareholders.

Superior customer experience

– The customer experience strategy of ESSA Pharma in industry is based on four key concepts – personalization, simplification of complex needs, prompt response, and continuous engagement.






Weaknesses of ESSA Pharma | Internal Strategic Factors
What are Weaknesses in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis

The weaknesses of ESSA Pharma are -

High dependence on ESSA Pharma ‘s star products

– The top 2 products and services of ESSA Pharma still accounts for major business revenue. This dependence on star products in industry has resulted into insufficient focus on developing new products, even though ESSA Pharma has relatively successful track record of launching new products.

Increasing silos among functional specialists

– The organizational structure of ESSA Pharma is dominated by functional specialists. It is not different from other players in the industry, but ESSA Pharma needs to de-silo the office environment to harness the true potential of its workforce. Secondly the de-silo will also help ESSA Pharma to focus more on services in the industry rather than just following the product oriented approach.

High operating costs

– Compare to the competitors, ESSA Pharma has high operating costs in the industry. This can be harder to sustain given the new emerging competition from nimble players who are using technology to attract ESSA Pharma lucrative customers.

Workers concerns about automation

– As automation is fast increasing in the industry, ESSA Pharma needs to come up with a strategy to reduce the workers concern regarding automation. Without a clear strategy, it could lead to disruption and uncertainty within the organization.

High dependence on existing supply chain

– The disruption in the global supply chains because of the Covid-19 pandemic and blockage of the Suez Canal illustrated the fragile nature of ESSA Pharma supply chain. Even after few cautionary changes, ESSA Pharma is still heavily dependent upon the existing supply chain. The existing supply chain though brings in cost efficiencies but it has left ESSA Pharma vulnerable to further global disruptions in South East Asia.

Lack of clear differentiation of ESSA Pharma products

– To increase the profitability and margins on the products, ESSA Pharma needs to provide more differentiated products than what it is currently offering in the marketplace.

Ability to respond to the competition

– As the decision making is very deliberative at ESSA Pharma, in the dynamic environment of industry it has struggled to respond to the nimble upstart competition. ESSA Pharma has reasonably good record with similar level competitors but it has struggled with new entrants taking away niches of its business.

Low market penetration in new markets

– Outside its home market of United States, ESSA Pharma needs to spend more promotional, marketing, and advertising efforts to penetrate international markets.

High bargaining power of channel partners in industry

– because of the regulatory requirements in United States, ESSA Pharma is facing high bargaining power of the channel partners. So far it has not able to streamline the operations to reduce the bargaining power of the value chain partners in the industry.

Products dominated business model

– Even though ESSA Pharma has some of the most successful models in the industry, this business model has made each new product launch extremely critical for continuous financial growth of the organization. ESSA Pharma should strive to include more intangible value offerings along with its core products and services.

Slow decision making process

– As mentioned earlier in the report, ESSA Pharma has a very deliberative decision making approach. This approach has resulted in prudent decisions, but it has also resulted in missing opportunities in the industry over the last five years. ESSA Pharma even though has strong showing on digital transformation primary two stages, it has struggled to capitalize the power of digital transformation in marketing efforts and new venture efforts.




ESSA Pharma Opportunities | External Strategic Factors
What are Opportunities in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis


The opportunities of ESSA Pharma are -

Low interest rates

– Even though inflation is raising its head in most developed economies, ESSA Pharma can still utilize the low interest rates to borrow money for capital investment. Secondly it can also use the increase of government spending in infrastructure projects to get new business.

Buying journey improvements

– ESSA Pharma can improve the customer journey of consumers in the industry by using analytics and artificial intelligence. It can provide automated chats to help consumers solve their own problems, provide online suggestions to get maximum out of the products and services, and help consumers to build a community where they can interact with each other to develop new features and uses.

Identify volunteer opportunities

– Covid-19 has impacted working population in two ways – it has led to people soul searching about their professional choices, resulting in mass resignation. Secondly it has encouraged people to do things that they are passionate about. This has opened opportunities for businesses to build volunteer oriented socially driven projects. ESSA Pharma can explore opportunities that can attract volunteers and are consistent with its mission and vision.

Learning at scale

– Online learning technologies has now opened space for ESSA Pharma to conduct training and development for its employees across the world. This will result in not only reducing the cost of training but also help employees in different part of the world to integrate with the headquarter work culture, ethos, and standards.

Redefining models of collaboration and team work

– As explained in the weaknesses section, ESSA Pharma is facing challenges because of the dominance of functional experts in the organization. ESSA Pharma can utilize new technology in the field of industry to build more coordinated teams and streamline operations and communications using tools such as CAD, Zoom, etc.

Reforming the budgeting process

- By establishing new metrics that will be used to evaluate both existing and potential projects ESSA Pharma can not only reduce the costs of the project but also help it in integrating the projects with other processes within the organization.

Leveraging digital technologies

– ESSA Pharma can leverage digital technologies such as artificial intelligence and machine learning to automate the production process, customer analytics to get better insights into consumer behavior, realtime digital dashboards to get better sales tracking, logistics and transportation, product tracking, etc.

Increase in government spending

– As the United States and other governments are increasing social spending and infrastructure spending to build economies post Covid-19, ESSA Pharma can use these opportunities to build new business models that can help the communities that ESSA Pharma operates in. Secondly it can use opportunities from government spending in sector.

Manufacturing automation

– ESSA Pharma can use the latest technology developments to improve its manufacturing and designing process in sector. It can use CAD and 3D printing to build a quick prototype and pilot testing products. It can leverage automation using machine learning and artificial intelligence to do faster production at lowers costs, and it can leverage the growth in satellite and tracking technologies to improve inventory management, transportation, and shipping.

Better consumer reach

– The expansion of the 5G network will help ESSA Pharma to increase its market reach. ESSA Pharma will be able to reach out to new customers. Secondly 5G will also provide technology framework to build new tools and products that can help more immersive consumer experience and faster consumer journey.

Lowering marketing communication costs

– 5G expansion will open new opportunities for ESSA Pharma in the field of marketing communication. It will bring down the cost of doing business, provide technology platform to build new products in the industry, and it will provide faster access to the consumers.

Use of Bitcoin and other crypto currencies for transactions in industry

– The popularity of Bitcoin and other crypto currencies as asset class and medium of transaction has opened new opportunities for ESSA Pharma in the industry. Now ESSA Pharma can target international markets with far fewer capital restrictions requirements than the existing system.

Using analytics as competitive advantage

– ESSA Pharma has spent a significant amount of money and effort to integrate analytics and machine learning into its operations in sector. This continuous investment in analytics has enabled ESSA Pharma to build a competitive advantage using analytics. The analytics driven competitive advantage can help ESSA Pharma to build faster Go To Market strategies, better consumer insights, developing relevant product features, and building a highly efficient supply chain.




Threats ESSA Pharma External Strategic Factors
What are Threats in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis


The threats of ESSA Pharma are -

Stagnating economy with rate increase

– ESSA Pharma can face lack of demand in the market place because of Fed actions to reduce inflation. This can lead to sluggish growth in the economy, lower demands, lower investments, higher borrowing costs, and consolidation in the industry.

Increasing wage structure of ESSA Pharma

– Post Covid-19 there is a sharp increase in the wages especially in the jobs that require interaction with people. The increasing wages can put downward pressure on the margins of ESSA Pharma.

Backlash against dominant players

– US Congress and other legislative arms of the government are getting tough on big business especially technology companies. The digital arm of ESSA Pharma business can come under increasing regulations regarding data privacy, data security, etc.

New competition

– After the dotcom bust of 2001, financial crisis of 2008-09, the business formation in US economy had declined. But in 2020 alone, there are more than 1.5 million new business applications in United States. This can lead to greater competition for ESSA Pharma in the sector and impact the bottomline of the organization.

High dependence on third party suppliers

– ESSA Pharma high dependence on third party suppliers can disrupt its processes and delivery mechanism. For example -the current troubles of car makers because of chip shortage is because the chip companies started producing chips for electronic companies rather than car manufacturers.

Increasing international competition and downward pressure on margins

– Apart from technology driven competitive advantage dilution, ESSA Pharma can face downward pressure on margins from increasing competition from international players. The international players have stable revenue in their home market and can use those resources to penetrate ESSA Pharma prominent markets.

Capital market disruption

– During the Covid-19, Dow Jones has touched record high. The valuations of a number of companies are way beyond their existing business model potential. This can lead to capital market correction which can put a number of suppliers, collaborators, value chain partners in great financial difficulty. It will directly impact the business of ESSA Pharma.

Environmental challenges

– ESSA Pharma needs to have a robust strategy against the disruptions arising from climate change and energy requirements. EU has identified it as key priority area and spending 30% of its 880 billion Euros European post Covid-19 recovery funds on green technology. ESSA Pharma can take advantage of this fund but it will also bring new competitors in the industry.

Learning curve for new practices

– As the technology based on artificial intelligence and machine learning platform is getting complex, ESSA Pharma may face longer learning curve for training and development of existing employees. This can open space for more nimble competitors in the field of sector.

Easy access to finance

– Easy access to finance in industry will also reduce the barriers to entry in the industry, thus putting downward pressure on the prices because of increasing competition. ESSA Pharma can utilize it by borrowing at lower rates and invest it into research and development, capital expenditure to fortify its core competitive advantage.

Barriers of entry lowering

– As technology is more democratized, the barriers to entry to industry are lowering. It can presents ESSA Pharma with greater competitive threats in the near to medium future. Secondly it will also put downward pressure on pricing throughout the sector.

High level of anxiety and lack of motivation

– the Great Resignation in United States is the sign of broader dissatisfaction among the workforce in United States. ESSA Pharma needs to understand the core reasons impacting the industry. This will help it in building a better workplace.

Regulatory challenges

– ESSA Pharma needs to prepare for regulatory challenges as consumer protection groups and other pressure groups are vigorously advocating for more regulations on big business - to reduce inequality, to create a level playing field, to product data privacy and consumer privacy, to reduce the influence of big money on democratic institutions, etc. This can lead to significant changes in the industry regulations.




Weighted SWOT Analysis of ESSA Pharma Template, Example


Not all factors mentioned under the Strengths, Weakness, Opportunities, and Threats quadrants in the SWOT Analysis are equal. Managers at ESSA Pharma needs to zero down on the relative importance of each factor mentioned in the Strengths, Weakness, Opportunities, and Threats quadrants. We can provide the relative importance to each factor by assigning relative weights. Weighted SWOT analysis process is a three stage process –

First stage for doing weighted SWOT analysis of ESSA Pharma is to rank the strengths and weaknesses of the organization. This will help you to assess the most important strengths and weaknesses of the firm and which one of the strengths and weaknesses mentioned in the initial lists are marginal and can be left out.

Second stage for conducting weighted SWOT analysis of ESSA Pharma is to give probabilities to the external strategic factors thus better understanding the opportunities and threats arising out of macro environment changes and developments.

Third stage of constructing weighted SWOT analysis of ESSA Pharma to provide strategic recommendations includes – joining likelihood of external strategic factors such as opportunities and threats to the internal strategic factors – strengths and weaknesses. You should start with external factors as they will provide the direction of the overall industry. Secondly by joining probabilities with internal strategic factors can help the company not only strategic fit but also the most probably strategic trade-off that ESSA Pharma needs to make to build a sustainable competitive advantage.



--- ---

Jiangsu Luokai Mechanical SWOT Analysis / TOWS Matrix

Technology , Electronic Instr. & Controls


OCI NV SWOT Analysis / TOWS Matrix

Basic Materials , Chemical Manufacturing


SP Group SWOT Analysis / TOWS Matrix

Basic Materials , Chemicals - Plastics & Rubber


Drax Group SWOT Analysis / TOWS Matrix

Utilities , Electric Utilities


Sri Krishna Metcom SWOT Analysis / TOWS Matrix

Consumer/Non-Cyclical , Food Processing


Magyar Telekom Plc SWOT Analysis / TOWS Matrix

Services , Communications Services


Murakami SWOT Analysis / TOWS Matrix

Consumer Cyclical , Auto & Truck Parts


PPK Group Ltd SWOT Analysis / TOWS Matrix

Capital Goods , Constr. & Agric. Machinery